Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Meclozine

A first-generation antihistamine of the piperazine family, patented in 1951 and in use since 1953 for motion sickness, with nausea, vomiting and dizziness, and for vertigo, including that of Ménière's disease. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.

Did you know?It has two official names: meclozine in Italy and most of Europe, meclizine in the United States, where in 2023 it was among the most prescribed medicines, with more than 4 million prescriptions.

MeclozineGo to the active ingredient →
MeclozineActive ingredientMeclozineCat. No. P-M023-001CAS 569-65-3

EDQM standards 3

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.